• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Brca1、Brca2、Palb2和Trp53在乳腺肿瘤发生中的基因相互作用。

Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development.

作者信息

Huo Yanying, Selenica Pier, Mahdi Amar H, Pareja Fresia, Kyker-Snowman Kelly, Chen Ying, Kumar Rahul, Da Cruz Paula Arnaud, Basili Thais, Brown David N, Pei Xin, Riaz Nadeem, Tan Yongmei, Huang Yu-Xiu, Li Tao, Barnard Nicola J, Reis-Filho Jorge S, Weigelt Britta, Xia Bing

机构信息

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

出版信息

NPJ Breast Cancer. 2021 Apr 23;7(1):45. doi: 10.1038/s41523-021-00253-5.

DOI:10.1038/s41523-021-00253-5
PMID:33893322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8065161/
Abstract

Inherited mutations in BRCA1, BRCA2, and PALB2 cause a high risk of breast cancer. Here, we conducted parallel conditional knockout (CKO) of Brca1, Palb2, and Brca2, individually and in combination, along with one copy of Trp53, in the mammary gland of nulliparous female mice. We observed a functional equivalence of the three genes in their basic tumor-suppressive activity, a linear epistasis of Palb2 and Brca2, but complementary roles of Brca1 and Palb2 in mammary tumor suppression, as combined ablation of either Palb2 or Brca2 with Brca1 led to delayed tumor formation. Whole-exome sequencing (WES) revealed both similarities and differences between Brca1 and Palb2 or Brca2 null tumors. Analyses of mouse mammary glands and cultured human cells showed that combined loss of BRCA1 and PALB2 led to high levels of reactive oxygen species (ROS) and increased apoptosis, implicating oxidative stress in the delayed tumor development in Brca1;Palb2 double CKO mice. The functional complementarity between BRCA1 and PALB2/BRCA2 and the role of ROS in tumorigenesis require further investigation.

摘要

BRCA1、BRCA2和PALB2的遗传性突变会导致患乳腺癌的高风险。在此,我们在未生育雌性小鼠的乳腺中分别单独或联合对Brca1、Palb2和Brca2进行平行条件性敲除(CKO),同时保留一份Trp53。我们观察到这三个基因在其基本肿瘤抑制活性方面具有功能等效性,Palb2和Brca2存在线性上位效应,但Brca1和Palb2在乳腺肿瘤抑制中具有互补作用,因为Palb2或Brca2与Brca1联合缺失会导致肿瘤形成延迟。全外显子测序(WES)揭示了Brca1与Palb2或Brca2缺失肿瘤之间的异同。对小鼠乳腺和培养的人类细胞的分析表明,BRCA1和PALB2的联合缺失导致高水平的活性氧(ROS)并增加细胞凋亡,这表明氧化应激与Brca1;Palb2双CKO小鼠的肿瘤发生延迟有关。BRCA1与PALB2/BRCA2之间的功能互补性以及ROS在肿瘤发生中的作用需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/748e92c499eb/41523_2021_253_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/080fc3ff04c2/41523_2021_253_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/0007355000be/41523_2021_253_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/191904428032/41523_2021_253_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/e45fc1ea7212/41523_2021_253_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/748e92c499eb/41523_2021_253_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/080fc3ff04c2/41523_2021_253_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/0007355000be/41523_2021_253_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/191904428032/41523_2021_253_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/e45fc1ea7212/41523_2021_253_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a7/8065161/748e92c499eb/41523_2021_253_Fig5_HTML.jpg

相似文献

1
Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development.Brca1、Brca2、Palb2和Trp53在乳腺肿瘤发生中的基因相互作用。
NPJ Breast Cancer. 2021 Apr 23;7(1):45. doi: 10.1038/s41523-021-00253-5.
2
Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice.BRCA1与PALB2相互作用的丧失会加速小鼠中与p53相关的肿瘤发展。
Genes Dis. 2020 Sep 5;9(3):807-813. doi: 10.1016/j.gendis.2020.08.012. eCollection 2022 May.
3
Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.Palb2 与 Trp53 协同作用,抑制遗传性乳腺癌模型中的乳腺肿瘤形成。
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8632-7. doi: 10.1073/pnas.1305362110. Epub 2013 May 8.
4
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.924 例台湾乳腺癌肿瘤靶向测序标本中 BRCA1、BRCA2 和 PALB2 基因改变的流行率:VGH-TAYLOR 研究的扩展数据分析。
Breast Cancer Res. 2023 Dec 14;25(1):152. doi: 10.1186/s13058-023-01751-z.
5
A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair.BRCA1 卷曲螺旋结构域变异破坏 PALB2 相互作用,促进乳腺肿瘤的发展,并赋予同源重组修复的靶向缺陷。
Cancer Res. 2021 Dec 15;81(24):6171-6182. doi: 10.1158/0008-5472.CAN-21-1415. Epub 2021 Sep 21.
6
Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.家族性胰腺癌的小鼠模型:Palb2、Brca1 和 Brca2 基因突变小鼠系中肿瘤的组织病理学、潜伏期和药物敏感性。
PLoS One. 2019 Dec 26;14(12):e0226714. doi: 10.1371/journal.pone.0226714. eCollection 2019.
7
Mutations of , , and Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis.乳腺癌组织中 、 、 基因的突变:与新辅助化疗效果及疾病预后的关系。
Genes (Basel). 2023 Jul 28;14(8):1554. doi: 10.3390/genes14081554.
8
Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.自噬拮抗 p53 介导的肿瘤屏障,促进 PALB2 相关遗传性乳腺癌模型中的肿瘤发生。
Cancer Discov. 2013 Aug;3(8):894-907. doi: 10.1158/2159-8290.CD-13-0011. Epub 2013 May 6.
9
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.全外显子组测序和靶向基因测序揭示了 PALB2 作为男性乳腺癌易感性基因的作用。
Cancer. 2017 Jan 1;123(2):210-218. doi: 10.1002/cncr.30337. Epub 2016 Sep 20.
10
Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours.Brca2和Trp53基因缺陷型小鼠乳腺肿瘤的全外显子组DNA序列分析
J Pathol. 2015 Jun;236(2):186-200. doi: 10.1002/path.4517. Epub 2015 Apr 2.

引用本文的文献

1
Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy.卵巢癌的治疗靶点:纳米增强型CRISPR/Cas9基因编辑与联合药物治疗
Int J Nanomedicine. 2025 Mar 30;20:3907-3931. doi: 10.2147/IJN.S507688. eCollection 2025.
2
Navigating the dichotomy of reactive oxygen, nitrogen, and sulfur species: detection strategies and therapeutic interventions.应对活性氧、氮和硫物种的二分法:检测策略与治疗干预
RSC Chem Biol. 2025 Jan 17;6(3):338-357. doi: 10.1039/d5cb00006h. eCollection 2025 Mar 5.
3
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors.

本文引用的文献

1
A Population-Based Study of Genes Previously Implicated in Breast Cancer.基于人群的先前与乳腺癌相关的基因研究。
N Engl J Med. 2021 Feb 4;384(5):440-451. doi: 10.1056/NEJMoa2005936. Epub 2021 Jan 20.
2
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
3
Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families.与生殖系致病性变异相关的癌症风险:一项对524个家庭的国际研究。
多组学分析揭示了 BRCA1 缺陷型与 BRCA2 缺陷型乳腺肿瘤中 PARPi 耐药的不同非逆转机制。
Cell Rep. 2023 May 30;42(5):112538. doi: 10.1016/j.celrep.2023.112538. Epub 2023 May 19.
4
Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer.遗传性乳腺癌患者队列中双杂合致病性变异的患病率
Front Oncol. 2022 Aug 8;12:873395. doi: 10.3389/fonc.2022.873395. eCollection 2022.
5
Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration.抑癌基因 PALB2 可维持大脑的氧化还原和线粒体稳态,并与 ATG7/自噬协同作用抑制神经退行性变。
PLoS Genet. 2022 Apr 11;18(4):e1010138. doi: 10.1371/journal.pgen.1010138. eCollection 2022 Apr.
6
Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway.环状 RNA_0006014 通过海绵吸附 miR-885-3p 来调节 NTRK2 和 PI3K/AKT 通路促进乳腺癌进展。
Aging (Albany NY). 2022 Apr 5;14(7):3105-3128. doi: 10.18632/aging.203996.
7
BRCA1 Versus BRCA2 and PARP Inhibitors Efficacy in Solid Tumors:A Meta-Analysis of Randomized Controlled Trials.BRCA1与BRCA2及PARP抑制剂在实体瘤中的疗效:一项随机对照试验的荟萃分析
Front Oncol. 2021 Oct 28;11:718871. doi: 10.3389/fonc.2021.718871. eCollection 2021.
8
heterozygosity and replication stress drive esophageal cancer development in a mouse model.杂合性缺失和复制应激驱动小鼠模型中的食管癌发生。
Proc Natl Acad Sci U S A. 2021 Oct 12;118(41). doi: 10.1073/pnas.2108421118.
J Clin Oncol. 2020 Mar 1;38(7):674-685. doi: 10.1200/JCO.19.01907. Epub 2019 Dec 16.
4
Homologous recombination DNA repair defects in associated breast cancers.相关乳腺癌中的同源重组DNA修复缺陷
NPJ Breast Cancer. 2019 Aug 8;5:23. doi: 10.1038/s41523-019-0115-9. eCollection 2019.
5
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.比较肿瘤基因组学鉴定了 BRCA1 突变型乳腺癌中驱动基因和药物靶点的组合。
Nat Commun. 2019 Jan 23;10(1):397. doi: 10.1038/s41467-019-08301-2.
6
Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.同源定向修复以及BRCA1、BRCA2和相关蛋白在基因组完整性和癌症中的作用。
Annu Rev Cancer Biol. 2018 Mar;2:313-336. doi: 10.1146/annurev-cancerbio-030617-050502. Epub 2017 Dec 1.
7
PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.PALB2 在 G2/M 检验点反应中连接 BRCA1 和 BRCA2。
Oncogene. 2019 Mar;38(10):1585-1596. doi: 10.1038/s41388-018-0535-2. Epub 2018 Oct 18.
8
Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1-PALB2 Interaction.BRCA1-PALB2 相互作用失活的小鼠组织间 DNA 损伤反应差异的证据及 NF-κB 的致癌作用。
Cancer Res. 2018 Jul 15;78(14):3969-3981. doi: 10.1158/0008-5472.CAN-18-0388. Epub 2018 May 8.
9
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer.鉴定和靶向三阴性乳腺癌小鼠模型中的散发性致癌基因突变。
Cancer Discov. 2018 Mar;8(3):354-369. doi: 10.1158/2159-8290.CD-17-0679. Epub 2017 Dec 4.
10
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes.同源重组DNA修复基因双等位基因改变的泛癌分析
Nat Commun. 2017 Oct 11;8(1):857. doi: 10.1038/s41467-017-00921-w.